Albany, NY -- (SBWIRE) -- 11/06/2018 -- Since the start of Human Microbiome Project, human microbiome is drawing interest from small and big players alike in the healthcare industry. Besides this, gaining traction from academia as the sector aim towards revolutionize treatments offered for various diseases. A recent study added to ResearchMoz.us, titled "Global Microbiome Therapeutics & Diagnostics Market Analysis & Forecast to 2023," studies various factors helping the market grow. In addition to this, the report also provides a detailed analysis of the restraints hindering the market's trajectory. It is intended to help stakeholders gain a comprehensive overview of the global microbiome therapeutics and diagnostics market.
The market in the coming years is likely to gain from innovations in human microniome products. However, research and development in the filed continues to pose various challenges. As per recent studies, collaborations have thus become important for market players to overcome technology and scientific challenges, intellectual property barriers, and regulation and manufacturing obstacles. This is expected to spur the global microbiome therapeutics and diagnostics market
Get a Sample PDF: https://www.researchmoz.us/enquiry.php?type=S&repid=1901599
Recent advances in next-generation sequencing and metagenomics have made microbiome diagnostics cheaper and easier, paving way to conduct analysis of genomic contents in human samples. This in turn has bolstered development of microbiome diagnostics in turn creating opportunities for the market's growth. According to the report, the global microbiome therapeutics and diagnostics market will rise at a CAGR of 19.03% between 2018 and 2023. Driven at this pace, the market will reach U$2.7 bn by the end of 2023, from US$1.13 bn in 2018.
In order to present an executive-level blueprint, the report segments the global market on the basis of diagnostics and therapeutics. In terms of therapeutics, the global microbiome therapeutics and diagnostics market can be segmented into probiotics, prebiotics, small molecules, fecal microbiota transplantation, and others. Besides this, the report segments the market in terms of application and regions. Regionally, the global market can be segmented into Europe, North America, the Middle East and Africa, Asia Pacific, and Rest of the World. In doing so, the report analyzes various factors impacting the market's trajectory across these segments.
The report also studies in detail the prevailing trends and business environment in the global microbiome therapeutics market. It presents insights into product pipelines and clinical trials. Based on detailed study, the report offers refined forecasts for the global market. Furthermore, it profiles some of the leading market players. Companies profiled in the report are 4D Pharma, Assembly Biosciences, C3J Therapeutics, Finch Therapeutics, Matrisys Bioscience, and others. It conducts SWOT analysis on the companies profiled to study their strengths and weaknesses and provide insights into opportunities and threats these companies are likely to witness in the forthcoming years. The report therefore offers an executive-level blueprint of the global microbiome therapeutics and diagnostics market.